Could a new drug combo cut lung infection treatment time in half?

NCT ID NCT07213765

Recruiting now Disease control Sponsor: Bin Cao Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 26 times

Summary

This study tests if adding a new antibiotic (contezolid) to the usual treatment can shorten therapy for a chronic lung infection called MAC. About 188 adults will either take the standard drugs for 12 months or the standard drugs plus contezolid for 6 months. Researchers will check if the infection clears faster and if quality of life improves.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Anhui Chest Hospital
RECRUITING

Hefei, Anhui, China
Beijing Chest Hospital, Capital Medical University
RECRUITING

Beijing, Beijing Municipality, China
China-Japan Friendship Hospital
RECRUITING

Beijing, Beijing Municipality, China
Guangzhou Chest Hospital
NOT_YET_RECRUITING

Guangzhou, Guangdong, China
Jiangxi Chest Hospital
RECRUITING

Nanchang, Jiangxi, China
Shanghai Pulmonary Hospital
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, China

Conditions

Explore the condition pages connected to this study.

MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE